Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 28, 2025 08:00 ET | Source: Super League Enterprise

Super League Announces Additional Close in Private Placement Offering Based on Strong Demand, Securing a Total of $20 Million in Gross Proceeds

~ With Offering Over-Subscribed, Company Completes Financing at the Maximum Offering Amount ~ SANTA MONICA, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE) (the “Company”), a...
October 24, 2025 16:05 ET | Source: Super League Enterprise

Super League Announces Follow On Close of Private Placement Offering, Securing Total of $17.9 Million

Super League Announces Follow On Close of Private Placement Offering, Securing Total of $17.9 Million
October 22, 2025 16:28 ET | Source: Super League Enterprise

Super League Announces $15.25 Million Private Placement Led by Strategic Digital Asset Investor Evo Fund, Strengthening Balance Sheet and Fortifying Shareholders Equity to Meet Nasdaq Requirements

~ Company Will Be Debt Free, Fully-Capitalized, and Poised for Expansion into the Digital Asset Economy ~ SANTA MONICA, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE) (the...
October 22, 2025 12:17 ET | Source: Judicate West

Judicate West Adds Judge Timothy B. Taylor in San Diego

SAN DIEGO, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Judicate West, one of California’s leading providers of private dispute resolution services, has added retired San Diego County Superior Court Judge...
October 16, 2025 16:05 ET | Source: RxSight, Inc.

RxSight, Inc. to Feature Live Learning Sessions at American Academy of Ophthalmology 2025 Annual Meeting

ALISO VIEJO, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following...
October 16, 2025 07:00 ET | Source: EyePoint Pharmaceuticals, Inc.

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

WATERTOWN, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of...
October 16, 2025 06:00 ET | Source: Fiverr International Ltd.

Fiverr Survey Debunks Gig Economy Myths: Freelancers Lead With Discipline, Flexibility, and AI

To commemorate International Freelancer Day on October 16, Fiverr is launching limited-time giveaways, a community rewards store, and Freelancer Tuesdays
October 14, 2025 22:43 ET | Source: EyePoint Pharmaceuticals, Inc.

EyePoint Announces Pricing of Public Offering

WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives...
October 14, 2025 16:35 ET | Source: EyePoint Pharmaceuticals, Inc.

EyePoint Announces Proposed Public Offering of Common Stock

WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives...
October 14, 2025 16:01 ET | Source: EyePoint Pharmaceuticals, Inc.

EyePoint Announces Pivotal Phase 3 Program Initiation for DURAVYU™ in Diabetic Macular Edema

– DURAVYU now in Phase 3 for the two largest, multi-billion-dollar retinal disease markets, wet AMD and DME with first patient dosing in pivotal Phase 3 DME trials anticipated in Q1 2026 – – New...